$VICL Brickell Biotech, Inc. Insider Trading
Get free email notifications about insider trading in Brickell Biotech, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Brickell Biotech, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Brickell Biotech, Inc. for free.
CIK Number: 0000819050
IRS Number: 930948554
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: VICL
Company Address: 5777 CENTRAL AVENUE SUITE 102 BOULDER 80301
Former name: VICAL INC, date of change: 1994-02-11
Market Capitalization: $24.86M
Prev close: $2.13
Average Daily Volume: 59,884
Days Low: $2.07
Year Low: $2.05
Year High: $4.80
Brickell Biotech, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 17 2021 | VICL | Brickell Biotech, ... | Breton Jose | Chief Accounting Of ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
Mar 17 2021 | VICL | Brickell Biotech, ... | Breton Jose | Chief Accounting Of ... | Payment of Exercise | F | 1.14 | 5,250 | 5,985 | 11,919 | 17.2 K to 11.9 K (-30.58 %) |
Mar 17 2021 | VICL | Brickell Biotech, ... | Breton Jose | Chief Accounting Of ... | Buy | M | 0.00 | 15,000 | 0 | 17,169 | 2.2 K to 17.2 K (+691.56 %) |
Mar 17 2021 | VICL | Brickell Biotech, ... | Chadha Deepak | Chief Research & De ... | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
Mar 17 2021 | VICL | Brickell Biotech, ... | Chadha Deepak | Chief Research & De ... | Payment of Exercise | F | 1.14 | 8,750 | 9,975 | 62,967 | 71.7 K to 63 K (-12.20 %) |
Mar 17 2021 | VICL | Brickell Biotech, ... | Chadha Deepak | Chief Research & De ... | Buy | M | 0.00 | 25,000 | 0 | 71,717 | 46.7 K to 71.7 K (+53.51 %) |
Mar 17 2021 | VICL | Brickell Biotech, ... | McAvoy David R. | General Counsel and ... | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
Mar 17 2021 | VICL | Brickell Biotech, ... | McAvoy David R. | General Counsel and ... | Payment of Exercise | F | 1.14 | 8,750 | 9,975 | 92,133 | 100.9 K to 92.1 K (-8.67 %) |
Mar 17 2021 | VICL | Brickell Biotech, ... | McAvoy David R. | General Counsel and ... | Buy | M | 0.00 | 25,000 | 0 | 100,883 | 75.9 K to 100.9 K (+32.95 %) |
Mar 17 2021 | VICL | Brickell Biotech, ... | Breton Jose | Chief Accounting Of ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
Mar 17 2021 | VICL | Brickell Biotech, ... | Breton Jose | Chief Accounting Of ... | Payment of Exercise | F | 1.14 | 5,250 | 5,985 | 11,919 | 17.2 K to 11.9 K (-30.58 %) |
Mar 17 2021 | VICL | Brickell Biotech, ... | Breton Jose | Chief Accounting Of ... | Buy | M | 0.00 | 15,000 | 0 | 17,169 | 2.2 K to 17.2 K (+691.56 %) |
Mar 17 2021 | VICL | Brickell Biotech, ... | Chadha Deepak | Chief Research & De ... | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
Mar 17 2021 | VICL | Brickell Biotech, ... | Sklawer Andrew D | COO and Secretary | Option Exercise | M | 0.00 | 20,000 | 0 | 0 | |
Mar 17 2021 | VICL | Brickell Biotech, ... | Chadha Deepak | Chief Research & De ... | Payment of Exercise | F | 1.14 | 8,750 | 9,975 | 62,967 | 71.7 K to 63 K (-12.20 %) |